Format

Send to

Choose Destination
Arch Pediatr. 2011 Oct;18(10):1084-6. doi: 10.1016/j.arcped.2011.07.023. Epub 2011 Aug 31.

[Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?].

[Article in French]

Author information

1
Service de néonatologie, hôpital Armand-Trousseau, faculté de médecine, AP-HP, université Pierre-et-Marie-Curie, 26, avenue du Dr-Arnold-Netter, 75571 Paris cedex 12, France.

Abstract

Curative treatment of congenital toxoplasmosis is based on the association of pyrimethamine and sulfonamide. There is currently no pediatric galenic formulation. We report the case of a newborn child affected by asymptomatic congenital toxoplasmosis who received an overdose of pyrimethamine. The patient received a dose of pyrimethamine 4 times, equal to 100 times the recommended dose, due to an error in the prescription. He had partial seizures 48 h after the last medicinal absorption. We noted a lack of appetite and vomiting, with a favorable progression in 5 days. Blood analysis showed isolated, spontaneously regressive moderate cholestasis. We propose a pharmacological clarification on the treatment of congenital toxoplasmosis.

PMID:
21885264
DOI:
10.1016/j.arcped.2011.07.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center